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Abstract
We report on the fabrication of arrays of mono- and multimetallic particles via metal evaporation
onto lithographically patterned posts, as well as the magnetic force calibration and successful
magnetofection of iron particles grown via this method. This work represents the first instance in
which metal evaporation onto post structures was used for the formation of released, shape-defined
metal particles. Also, our work represents the first use of lithographically defined particles as agents
of magnetofection. Using these techniques it is possible to create particles with complex shapes and
lateral dimensions as small as 40 nm. Our demonstrated compositionally flexible particles are highly
size-uniform due to their photolithographically defined growth substrates, with particle dimensions
along two axes fixed at 200 nm; the third axis dimension can be varied from 20 nm to 300 nm during
the deposition procedure. Atomic percent of metals incorporated into the particle volume is highly
tunable and particles have been synthesized with as many as four different metals. We performed
magnetic force calibrations on a single particle size for iron particles using an axially magnetized
NeFeB permanent magnet and comparisons are made with commercially available magnetic beads.
In order to evalutate their usefulness as magnetofection agents, an antisense oligonucleotide (ODN)
designed to correct the aberrant splicing of enhanced green fluorescent protein mRNA, was
successfully transfected into a modified HeLa cell line. Magnetically enhanced gene delivery was
accomplished in vitro using antisense ODN-laden iron particles followed by application of a field
gradient. Magnetically enhanced transfection resulted in a 76% and 139% increase in fluorescence
intensity when compared to Lipofectamine and antisense ODN-loaded particles delivered without
magnetic treatment, respectively. To our knowledge, these experiments constitute the first use of
lithographically defined particles as successful agents for magnetically enhanced transfection of an
antisense oligonucleotide.
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Magnetic micro- and nanoparticles with a wide array of chemical and physical properties have
been synthesized, characterized, modified, and utilized in materials science, biology and
biochemistry.1, 2 These particles have undergone particularly intense research due to their
ability to interact chemically and biologically with a sample while providing the experimenter
with a physical means by which to spatially manipulate the particle and its bound payload.3
Attaching therapeutic agents,4 DNA,5 or antisense oligonucleotides6 to magnetic particles for
drug delivery applications has proven successful in an array of cell lines. Specifically,
researchers have been effective in utilizing magnetic field gradients to increase the interaction
probability and, consequently, the transfection efficacy, of various moieties attached to
magnetic particles.
Although techniques have been developed to fabricate particles in the size range of 40 nm and
below, there is a dearth of strategies for size uniform particles in the range of 20 nm to 1 micron.
We present a technique that is capable of defining the lateral shape of the particle down to the
resolution of lithography (~20 nm for electron beam lithography) while precisely controlling
the particle composition and structure through sequential deposition of user selected metals or
dielectrics.
Previous magnetofection experiments have been performed almost exclusively with
commercially available colloidal polymer-iron oxide particles created via wet chemistry
techniques.6 Particles grown using photolithographic ally defined templates have been
successfully transfected into cells,7 however more effective delivery of an antisense ODN using
these types of particles in conjunction with magnetofection protocols has not yet been reported.
The ability to incorporate a variety of metals into a single particle and modulate each metal’s
concentration allows user-specific tunability on a single wafer platform, thereby expanding the
metallic particle toolbox. Utilizing the various properties of metals also makes possible
particles with an array of designed surface chemistries. For example, Fe3O4@Ag particles were
recently developed, used as antimicrobial agents, and magnetically reclaimed from water
samples;8 Park et al. were successful in tuning the catalytic oxidation of CO by changing the
composition ratios of Rh–Pt nanoparticles.9 Also, FePt particles were synthesized and
functionalized so as to produce photoswitchable ferromagnetic nanoparticles capable of
operating at room temperature.10 Optically controlling a particle’s magnetic properties is an
important step in realizing high density optical memory.10
Magnetofection aims to increase transfection rate by bringing the relevant gene in rapid and
direct contact with a cell membrane, as well as decrease the amount of vector necessary for a
single assay. While this is advantageous for in vitro experiments, the tool’s major potential lies
in remote controlled vector targeting in vivo.11 Physical vapor deposition into ordered arrays
of holes or onto posts has been performed using interferometric lithography for use in memory
storage applications12, 13 and the magnetic properties of these arrays have been studied.14 More
recently, lithographically defined templates have been used to create polymeric particles with
exquisite control over particle shape and composition.15–18 These methods are excellent
examples of how patterned substrates offer flexibility in shape and composition which is
difficult to produce using strictly chemical methods. However, they differ from our procedure
in that they do not rely on metal evaporation onto a surface followed by particle harvesting.
We demonstrate the ability to create versatile, size uniform metal particles incorporating from
one to four metals in a single particle. We quantified the low-field particle susceptibility and
the forces generated on these fabricated particles and compared them with commercially
available particles. We demonstrate the usefulness of Fe particles made in this manner by the
successful magnetofection of iron/iron oxide particles into HeLa EGFP-654 cells. The
transfection successfully delivers antisense oligonucleotide, blocking a mutated, aberrant
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splice site contained in the EGFP pre-mRNA, resulting in expression of the green fluorescent
protein.
2. EXPERIMENTAL DETAILS
2.1. Lithographically Defined Photoresist Structures for Particle Fabrication
Standard photolithography techniques are used to produce 0.20 µm cylindrical posts 0.33 µm
tall with 0.70 µm pitch. Briefly, Si wafers (6″) are RCA-cleaned in preparation for
photolithography and an ASML 5500/950B Step and Scan photolithography tool (Triangle
National Lithography Center, Raleigh, North Carolina) is used to produce post structures. A
bottom antireflective coating (BARC) is applied to the wafer prior to photoresist deposition to
prevent interfering reflectance from the wafer surface. Following exposure, development and
liftoff a metal film is resistively evaporated onto the patterned wafer surface. The resulting
film is a laterally conformal layer of metal over the entire wafer surface, leaving only the
sidewalls of the vertical post structures exposed to solvents. Iron, iron–gold, nickel–gold–
palladium, and nickel–gold–palladium–cobalt particles were created using this method. After
metallization, templates were placed in acetone for 24 h, followed by sonication in acetone for
1 h, resulting in the dissolution of photoresist posts and release of evaporated particles
(hereafter referred to as Post-Particles).The lateral particle size dimensions were closely
defined by the patterned substrate. As shown in Figure 1, the patterned substrate resulted in
posts with hemispherical tops. The hemispherical top surfaces of these posts resulted in
particles which crescent shaped cross-sections. Figure 2(d) indicates this cross-sectional aspect
of the particle shape. Uniformity in lateral dimension is exhibited by the TEM images in Figure
3 in which particles are viewed top-down.
2.2. Force Calibration
To understand the applicability of our particles for magnetofection, we calibrate the force
generated on Fe particles created using this technique by an applied magnetic field gradient
through the application of Stokes law. Specifically, magnetic fields due to permanent magnets
or magnet arrays will play a role in future drug delivery applications of magnetic carriers.19–
22 Particle motion through water was characterized by applying a known field gradient (using
a NdFeB permanent magnet) to particles in a closed sample well (20 µl).In the low field limit,
the magnetic force on a particle is
(1)
where d is the bead diameter, µ0 is the relative permeability of free space (in SI units), and
µr is the relative permeability of the bead. A particle’s permeability is related to its susceptibility
via
(2)
If force, particle diameter, and magnetic field (B) are known, then µr can be determined using
Eq. (1). Susceptibility can then be calculated using Eq. (2).
The magnetic field and field gradient were measured to be sufficiently uniform over the 60 µm
field of view.23 Obtaining the solution viscosity (η), bead radius (ab), and the bead velocity
(v) allows us to use Stokes formula,
Mair et al. Page 3














to calculate the average force on each particle. Velocity measurements were also taken on
Micromod nanomag® - D PEG-COOH 250 nm particles (Micromod Partikel-technologie
GmbH) and Dynabeads® MyOne™ 1 µm iron oxide impregnated beads (Invitrogen) for
comparison. The magnetic field was measured in 250 µm increments along the axis of the
magnet; measurements were taken between 18 and 80 mm from the magnet face. A 100×
objective was used to image particles (in an epi-illumation configuration) and video was
collected at 20 frames per second using a Pulnix PTM-6710CL camera. Video tracking and
analysis software24 was used to calculate particle velocities under a given field gradient.
2.3. Attachment of Antisense Oligonucleotide to Fe Particles
Particles may be functionalized while still attached to their posts or after release from the wafer.
Polyethyleneimine is commonly used to bind DNA to particles11, 25–28 and is used here to
electrostatically interact with a EGFP-correcting oligodeoxyribonucleic acid (ODN).Resina et
al. have delivered splice-switching oligonucleotides to HeLa pLuc cells for the successful
modulation of a transgene.29 These antisense ODN constructs were synthesized using
phosphoramidite chemistry (courtesy of Md. Rowshon Alam, University of North Carolina at
Chapel Hill, Department of Pharmacology).30 Specifically, the oligomer consists of 20
nucleotides (5′-GTT ATT CTT TAG AAT GGT GC-3′) and is antisense to the cryptic splice
site activated on intron 2 of the IVS2-654 mutant beta-globin gene in the HeLa EGFP-654
cells. The ODN is modified with a 2′-O-methyl and phosphorothioate internucleotide
backbone, resulting in increased stability and protection against degradation by nucleases.
PEI was bound to the Fe Post-Particles by mixing the particles (1 mg/ml) with 0.1 mg PEI for
4 h in a DI water adjusted to pH 10 using 0.1 M NaOH. At this pH the zeta potential of the
particles is sufficiently low to electrostatically bind cationic PEI to the particle surface. To bind
the oligonucleotides, PEI-labeled particles (1 mg/mL) were mixed with oligonucleotide (50
µM) at a 5:1 ratio by volume with an equal part of phosphate buffered saline. This mixture was
allowed to rotate for 1 hour at room temperature. For Lipofectamine transfection experiments,
antisense oligonucleotide was complexed with Lipofectamine 2000 at a 1:1 volume ratio
(Invitrogen, Carlsbad, CA).Lipofectamine 2000 is a common transfection agent used for
introducing genes into cells, both transiently and stably.
2.4. Cell Culture and Magnetofection Experiments
The HeLa cell line EGFP-654 expresses a construct in which the coding region of the of
enhanced green fluorescent protein (EGFP) is interrupted by the mutated beta-globin intron.
The cell line is grown at 36.5 °C and 3.5% CO2 in Dulbecco’s Modified Eagle Medium with
F-12 nutrient mixture (Invitrogen, Carlsbad, CA) with L-glutamine and HEPES buffer
supplemented with 10% fetal bovine serum. Growth media was further supplemented with
10% antibiotic-antimycotic (Penicillin-Streptomyocin and Amphotericin B, Invtitrogen).
HeLa EGFP-654 cells were plated at 5000 cells per well 24 hours before transfection in a Nunc
384 well plate. Before transfection cell media was replaced with Opti-MEM I Reduced-Serum
Medium (Invitrogen, Carlsbad, CA).The cells were treated for 1 hour with a 200 nM dose of
antisense ODN complexed with 200 nm Fe nanoparticles with and without a permanent
magnetic field. Control experiments were performed using untreated and Lipofectamine treated
(no particles) HeLa EGFP-654 cells in order to compare the efficacy of gene transfection using
these particles. Also, in order to assess the differences between free-floating PEI-ODN complex
and particle and Lipofectamine transfections, PEI (50% w/w, 60,000 MW) was diluted 1:5000
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and conjugated with the antisense oligonucleotide. It was also added to the cell culture at 200
nM and allowed to incubate for 1 hour, at which time the media was replaced with fresh media.
For magnetic nanoparticle transfections one sample was placed over the NdFeB magnets for
1 hour and a second sample did not receive an external magnetic field. The media was changed
in all samples to D-MEM F-12 with 10% FBS after 1 hour. Replacing media after the field
application removed free-floating ODN-laden particles from the solution, as well as any free
ODN which may have separated from particles, thus eliminating the possibility for transfection
later in the experiment. The cells were incubated for an additional 23 hours before imaging.
The total duration of the experiment was 24 hours. After 24 hours fluorescence microscopy
was used to quantify the transfection efficacy. Treated and untreated cells were imaged using
a Nikon Eclipse TE 2000-E inverted optical microscope (Tokyo, Japan) with a 40× objective.
Images were taken using a Photometrics Cascade II 512 electron multiplying CCD digital
camera (Roper Scientific, Inc., Tuscon, AZ) and background fluorescence was established by
performing segmentation imaging on highest intensity cells in untreated samples. Cells
measuring above this background fluorescence in treated samples were measured for mean
intensity using segmentation. Mean background fluorescence was subtracted to determine the
true mean intensities above background for treated cells. An average of 20 images were taken
of each well and weighted mean intensities were summed over all images.
3. RESULTS AND DISCUSSION
3.1. Compositionally Diverse Particles
Using these templates particles with varying compositions have been made, including Fe, Fe–
Au, Ni–Au–Pd, and Ni–Au–Co–Pd particles. Energy-dispersive X-ray spectroscopy (EDS)
analysis was performed on five particle compositions using a Hitachi S-4700 FE-SEM. Three
of these particles were Fe–Au particles with varying metal ratios (particles a–c in Fig. 4), one
was a Au–Ni–Pd particle (particle d in Fig. 4), and the other was a Au–Co– Ni–Pd particle
(particle e in Fig. 4).For compositional analysis, all sample substrates were immersed in acetone
(using a 20 ml scintillation vial) for 24 h and sonicated for 1 h, after which the growth substrates
were removed from the scintillation vial and the particles were rinsed three times using
magnetic separation. Subsequently, particles were deposited from acetone onto Ted Pella
carbon sample substrates, concentrated under a magnetic field gradient, and imaged
immediately after drying. EDS data was collected at 13 kV accelerating voltage and 20 µA
beam current. Figure 4 indicates the five spectra that were collected along with the atomic
compositions of each particle batch created.
3.2. Force Calibration of Fe Post-Particles
We determined the forces on 1 µm superparamagnetic Dynabeads® MyOne™, 250 nm
superparamagnetic Micromod nanomag® particles, and 200 nm Fe Post-Particles. MyOne™
and Micromod particles were each diluted 1/10000 v/v prior to beginning force experiments.
Sample volumes were placed in a closed well to eliminate the effects of evaporation and sample
drift; the well was spaced a calibrated distance from the face of a permanent magnet. We
delivered 20 ul of diluted particle solution (25 °C) into the well and observed particle velocities.
We identified many-particle aggregates and aligned strings of particles and omitted them from
the tracking results. Due to their shape-uniformity, aggregates or aligned strings of two or more
MyOne™ beads were clearly evidenced by their lemniscate-shaped image and multi-particle
strings were not tracked. The shape heterogeneity of Micromod 250 nm particles makes single
particle identification more difficult. MyOne™ beads did not aggregate, while approximately
30% of objects in Post-Particle samples appeared to be incorporated into field-aligned particle
chains and 50% of objects in Micromod nanomag® samples were considered aggregates.
Although both Micromod and Post-Particles exhibited connected multi-particle groupings
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during the experiment, these groupings displayed drastically different morphological
characteristics within each sample. Micromod particles were observed as both spheres of
varying diameter and as field-aligned chains of particles. While aligned strings of Post-Particle
were observed, spherically shaped agglomerates of varying diameter were not seen. A reticule
was used to determine that the pixel dimension of the video data taken was 124 nm2. Particle
velocities were established using in-house particle tracking software.24 Tracked particles were
chosen based on dimensions of the particle image. Low-number collections (1–3 particles) of
Micromod and Post-Particles were not guaranteed exclusion from the tracked data due to their
size being close to the optical resolution limit of our microscope. Figure 5 shows the
displacement versus time data for the three particles tested.
From the observed particle velocities we calculated the applied forces on the particles due to
the magnetic field gradient via Stokes formula. We tracked 45 beads for each type of particle,
all tracks occurring in the same magnetic field gradient. Average velocities were 11.1 µm/s,
5.9 µm/s, and 10.7 µm/s for Dynabeads® MyOne™, Micromod 250 nm, and 200 nm Fe Post-
Particles, respectively; the resulting average forces applied to these beads were 138 ± 22 fN,
18 ± 2 fN, and 26 ± 5 fN for Dynabeads® MyOne™, Micromod 250 nm, and 200 nm Fe Post-
Particles, respectively. Although we have treated the resulting force histogram shown in Figure
6 as monomodal for all particle types, the shape of the Post-Particle distribution suggests a
bimodal force distribution for Fe Post-Particles, the first mode existing at 22 fN and the second
mode occurring at 30 fN. This indicates force data arising from two discrete populations,
namely a single particle population and a double particle population. An aligned pair or triplet
of particles is expected to experience more force in a given field and field gradient.
We use this force data to calculate susceptibility χv and magnetization M for each particle type.
As noted earlier, the force on compositionally equivalent particles which vary in size is
proportional to the cube of the particle diameter, F ~ d3.The force applied to a particle in the
low magnetic field limit depends on the particle volume (V ), the difference in magnetic
susceptibilities (Δχ) (between the particle susceptibility, χparticle, and the surrounding material’s
susceptibility, χsurround), and the field and field gradient of the magnetic field:
(4)
Particles we tested varied by size and composition. MyOne™ beads consist of γ-Fe2O3
dispersed in a polystyrene matrix and coated with a thin polymer layer; Micromod particles
consist of Fe3O4 dispersed in a silica-fortified polysaccharide matrix;31 200 nm Fe Post-
Particles are iron particles with a native oxide at the particle surface. Using Eq. (4) and the
calculated average forces applied to each type of particle we obtain the volumetric particle
susceptibilities. Using the calculated χv and the known magnetic field of 0.081 T, as well as
the relationships among B, M, and H [namely, χv = M/H and B = µ0(M + H)] we determine
each particle’s magnetization in the given 0.081 T field. These results are summarized in Table
I. The calculated magnetization, M, for the particles is equal to the magnetic moment per unit
volume, M = m/V. The magnetization value for Fe Post-Particles was only slightly higher than
that of the Micromod particles, while the susceptibilities for Fe Post-Particles was 171% larger
than that of Micromod particles.
We now compare our calculations for MyOne™ and Micromod particles with other reports.
Previously, researchers have recorded various values for the magnetization and volumetric
susceptibility of MyOne™ 32, 33 and Micromod34, 35 particles. Our measurements of MyOne™
bead susceptibility agrees with these previous reports; our measurements of Micromod bead
susceptibility is significantly higher than other reports. This strongly indicates that the
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Micromod particles tracked and tabulated during our experiment were actually small packets
of particles clumped together; our experiments yielding average per particle χv values of 200%
and 260% of those previously reported34, 35 indicates that these small packets typically
consisted of two or three particles attached to one another.
Understanding the force-to-size ratio for magnetic particles in a known field and field gradient
is crucial for informed estimates of particle translational performance. Importantly, this force-
to-size ratio is highly dependent upon the specific material(s) incorporated into a particle. Most
particles synthesized via wet chemical methods are composed of magnetite or maghemite.1 As
stated previously, for spherical particles of a given material in a given field, a 200 nm particle
would be expected to experience 0.80% and 51% of the force experienced by a 1 µm and 250
nm particle, respectively. Deviations from this pattern must indicate geometric or
compositional differences among the particles. Our 200 nm Post-Particles experienced a force
19% that exhibited by 1 µm Dynal beads and 144% that experienced by the Micromod particles,
drastically larger than the expected 0.80% and 51%, respectively. Although geometric
differences do exist among the particles tested, these differences are too small to cause such
large disparities in particle force. These large discrepancies in force mean that our Post-
Particles are made from a different material than either of the two commercially available
particles. These commercial particles are composed of iron oxide grains smaller than the single
domain size31, 36 and, consequently, MyOne™ and Micromod beads are both
superparamagnetic.31, 36 Collected video data of the absence of remanence-induced
aggregation confirmed this fact. In the absence of a magnetic field we observed that MyOne™–
MyOne™ and Micromod-Micromod bead collisions did not result in permanent bead
aggregation. This is expected for superparamagnetic particles. In the absence of a magnetic
field superparamagnetic beads have no remnant magnetization and therefore no permanent
dipole moments. Consequently, there were no dipole–dipole attractive forces between
superparamagnetic particles to cause aggregation. In contrast, chain-like aggregation outside
of a magnetic field was observed in our Post-Particles. Video data collected in the absence of
an applied field showed non-reversible particle chaining (the agglomerates were not included
in the force data), indicating that our Post-Particles were ferromagnetic. Ferromagnetic
particles, once exposed to a magnetic field, exhibit a net magnetization which exists inside the
volume despite the absence of an applied field. The fact that Post-Particles had comparatively
large force-to-size ratios (relative to MyOne™ and Micromod particles) in the applied field is
due to these differences in magnetic ordering. While MyOne™ and Micromod particles are
composed of sub-20 nm grains of uniformly oxidized iron (γ-Fe2O3 and Fe3O4, respectively),
36, 37 our Post-Particle fabrication technique essentially creates arrays of size-uniform metallic
clusters with grain sizes significantly larger than 20 nm. These grains are not uniformly
oxidized and contain segments of pure Fe; this is not present in either of the superparamagnetic
particles. This compositional difference explains the large discrepancy in actual and expected
force-to-size ratios for our Post-Particles due to the fact that ferromagnetic materials have larger
susceptibilities in a given field than do superparamagnetic materials. It should be noted that
we have used the equation χv = M/H to calculate magnetization for all particles. This assumption
does not hold precisely for ferromagnetic materials. The non-linear hysteresis loop of
ferromagnetic materials makes this only an approximation. We expect this to be an
underestimate as our experiments were performed in the low field range for ferromagnetic
particles and because in low fields hysteresis curves for ferromagnetic materials typically
exhibit steep slopes in small applied H fields.38
3.3. Magnetically Enhanced Cell Transfection
The general mechanism of the magnetic transfection starts with introducing the DNA-particle
complexes into the cell media. A magnetic field is applied to direct the particles to the cell
membrane. The particles come in contact with the cell membrane and are eventually taken into
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the cytoplasm via endocytosis. The particle becomes encapsulated by a membrane-bound
endosome as it is moved into the cellular interior. The PEI polymer has the capability to disrupt
this membrane through a process called endosomolysis.39 The PEI seems to elicit a substantial
proton influx into the endosome ensued by a passive chloride influx. This causes osmotic
swelling of the endosome, causing its rupture, and the subsequent release of the particle and
genetic products. From here, a certain portion of the DNA is released from the particle to
perform its designed function.
Although lithography techniques have gained popularity as a means of tailoring particle shape
and composition,15–17, 40 increased transfection via magnetofection using these types of
particles has yet to be reported. In order to test the comparative efficacy of EGFP turn-on via
particle delivery of ODN, five sets of cell treatments were established: untreated cells, cells
dosed with only the PEI-ODN complex, cells dosed with antisense ODN-bound 200 nm Fe
Post-Particles delivered without a magnetic field gradient, antisense ODN-bound 200 nm Fe
Post-Particles delivered in the presence of a field gradient, and Lipofectamine 2000. Figure 7
shows representative images from each treatment course. The efficacy of magnetofection using
our Post-Particles is clearly evidenced by the increased expression of EGFP. The increased
fluorescence is a product of particles penetrating the cell membrane, delivering antisense ODNs
to the cell nucleus, and aberrant splicing of EGFP pre-mRNA being corrected. Results from
segmentation analysis of EGFP-expressing cells indicate a 76% increase in fluorescence
intensity of ODN-loaded magnetic particles (with magnetic gradient applied) over
Lipofectamine as well as a 139% increase in intensity over the non-magnetic control (Fig. 8).
Also, as evidenced by images taken throughout the well, the rate of transfection was
significantly higher in the magnetic sample over the non-magnetic control.
Magnetofection experiments exhibited only low levels of cell death (less than 5% overall) as
observed through bright field microscopy and no evidence was seen that our particles increased
cytotoxicity. However, our transfection times were 1 hour, and as such, possibly not a long
enough time frame to accurately gauge toxicity levels. Toxicity experiments performed over
extended periods would provide greater information regarding the comparative toxicity of our
particles. Likewise, untreated HeLa EGFP-654 cells were unresponsive to the applied magnetic
field and showed no visible signs of increased cytotoxicity during the experiment. It has been
noted previously that an applied magnetic field enhances the transfection rate. The general
mechanism by which this increased endocytosis is not clear.41 It is accepted that the process
of magnetofection decreases the time necessary for cell–particle interactions to occur by
magnetically placing the ODN-laden particles spatially near or on the cell membrane.
Researchers have explored the application of oscillating fields41, 42 and have speculated that
the oscillating field increases efficiency of endocytosis and may also cause endosomal release.
4. CONCLUSION
Multimetallic particles via physical vapor deposition onto lithographically defined substrates
offers a method by which to produce highly size and shape uniform particles. Our technique
allows user-specific metal compositions and concentrations, making this technique useful for
tailoring the particle properties to a high degree. Particle velocities resulting from the
application of a known magnetic field gradient were used to calculate the average force applied
to particles and compare this with average forces applied to commercially available particles
in the same field gradient. Particle susceptibilities were calculated and compared with expected
values based on the particle composition. The significant forces applied to these nanoscale
particles in the applied field gradient makes them excellent candidates for biophysical force
experiments where small size is preferred, such as intracellular environments. Finally, results
represent the first time lithographically-templated particles have been used in conjunction with
magnetofection to deliver genes to cells.
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Schematic representation of the bi-metallic particle formation process.
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FE-SEM images detailing wafer surface through all stages of particle fabrication. (a)
Lithographically defined posts; (b) metallized wafers result in a post-cap structure; (c)
photoresist post dissolution is performed by soaking samples in acetone, leaving a cratered
surface with particles and photoresist posts segments in acetone; (d) Au–Ni–Pd particles
magnetically concentrated on a substrate. All scale bars are 2 µm.
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Images taken using a JEOL 2010 TEM. Images indicate spherical component of particle shape
as well as size uniformity.
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EDS data of compositionally diverse particles. All particles were created from 99.99% pure
metals (Sigma) and evaporated at 1 × 10−6 Torr from tungsten evaporation crucibles. This data
represents small subset of material design possible with our post fabrication method. Inset
image shows the target compositional profile of each particle type.
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Here we show the magnet response of the particles tested. (a) Blue traces represent 1 µm
Dynabeads® MyOne™ superparamagnetic beads; green traces represent Micromod 250 nm
particles; purple traces represent 200 nm Fe post-particles.
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A histogram representing forces applied to particles. Force calculations are based on Stokes
law and are calculated for each bead based on the tracked bead velocity. The inset represents
magnetic field measurements taken at 250 µm increments measured using an F. W. Bell model
5080 gaussmeter. A Ni–Cu–Ni coated NdFeB permanent magnet (1 in. diameter, 2 in. length,
K&J Magnetics) was used. A surface field of 6775 G was reported by the manufacturer.
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Representative images of (a) untreated cells, (b) PEI-ODN treated cells (c) particles labeled
with oligonucleotide (200 nM) delivered to cells without applied magnetic field; (d) particles
labeled with oligonucleotide (200 nM) delivered to cells with applied magnetic field; (e)
Lipofectamine delivered to cells.
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Average fluorescence intensities based on segmentation data collected across wells.
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MyOne™ 1.4 1.5[32], 1.38[33] 3.8
Micromod 12.6 6±2[34], 4.8[35] 6.0
Post-Particles 34.2 — 6.3
a
χv is the volumetric susceptibility and is a measure of how magnetizable a substance can become in a given magnetic field.
b
M is the intensity of magnetization and is defined as the quantity of magnetic moment per unit volume.
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